FibroGen (0IL8.L) Stock Price

$0.308 5.2%

Sign up
to add to portfolio

AI Score

Sell
  • Alternative

    5
  • Fundamental

    1
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on FibroGen, AI stock picks, stock alerts and much more.

Sign up

0IL8.L AI Stock Analysis

AI stock analysis for 0IL8.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like FibroGen (0IL8.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

FibroGen (0IL8.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of FibroGen (0IL8.L), currently trading at $0.308, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0IL8.L

LSE
  • FibroGen, Inc.

  • Symbol

    0IL8.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    30.1M

0IL8.L Alternative Data

Web Traffic

FibroGen receives an estimated 5957 monthly visitors to fibrogen.com.

  • Web Traffic

    5957

  • Change from Previous Month

    11.7%

  • 3 Month Change

    2.8%

  • YoY Change

    2.8%

Twitter Followers

FibroGen has 990 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.

  • Twitter Followers

    990

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.3%

Job Postings

FibroGen currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

FibroGen was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

LinkedIn Followers

16,803 are following FibroGen on LinkedIn, up by 0.4% over the last month.

  • LinkedIn Followers

    16803

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.4%

LinkedIn Employees

According to LinkedIn, FibroGen has 324 employees.

  • LinkedIn Employees

    324

  • Daily Change

    0.6%

  • 1 Month Change

    0%

  • 3 Month Change

    3.3%

Reddit Mentions

FibroGen has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at FibroGen is 45 out of 100 (neutral).

  • Business Outlook

    45

  • Change from Previous Month

    4.7%

  • 3 Month Change

    0%

  • YoY Change

    0%

0IL8.L Financials

0IL8.L Key Metrics
  • Total Revenue

    -$123.3M

  • Net Income

    $18M

  • Earnings per Share

    $0.18

  • Free cash flow

    -$30.6M

  • EBITDA

    -$91.1M

  • EBITDA Ratio

    0.739112

  • Total Assets

    $214.5M

0IL8.L 2-year Revenue & Income
0IL8.L 2-year Free Cash Flow

0IL8.L Technicals

0IL8.L SMA
0IL8.L RSI

FAQ

What's the current price of FibroGen (0IL8.L) Stock?
The price of an FibroGen (0IL8.L) share is $0.308.

What's the market cap of FibroGen?
The current market cap of FibroGen is 30.1M.

Should I buy or sell 0IL8.L?
FibroGen exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is FibroGen a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in FibroGen stock. There are several bearish signals and market challenges that could negatively impact FibroGen's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy FibroGen (0IL8.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy FibroGen stock right now, as the outlook appears bearish.

What are some stocks similar to FibroGen (0IL8.L) that investors often compare it to?
FibroGen (0IL8.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.

What is the forecast for FibroGen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast FibroGen's stock price to be around $0.307 in 2026. Starting from the current price of $0.308, this represents a 0.3% change in price, indicating a neutral outlook for the stock.

How to buy FibroGen (0IL8.L) Stock?
FibroGen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy FibroGen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.